Transitions in PAH Therapy (Dec 03, 2019 - Jun 30, 2020)

Transitions in PAH Therapy is organized by Washington University School of Medicine in St. Louis.

Publication Date: Dec 3, 2019
Expiration Date: Jun 30, 2020

Target Audience:
This course is designed for pulmonologists, intensivists, cardiologists, rheumatologists, internists, critical care physicians, primary care, nurses, nurse practitioners, physician assistants, pharmacists and other health professionals.

Accreditation:
Credits: 0.5

American Medical Association (AMA Credit):
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™.

Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
• Summarize indications for transitioning between therapies for PAH.
• Determine the need to "step-up" therapy for patients not meeting comprehensive treatment goals.
• Appreciate unique pharmacologic aspects different prostacyclin pathway activators.
• Apply pre-transition criteria for safely "stepping down" in therapy.
• Describe how to determine success after transition.

Additional details will be posted as soon as information is available.